Matthew McManus - 15 Aug 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
President - Diag & Spatial Bio
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
15 Aug 2025
Net transactions value
-$47,168
Form type
4
Filing time
19 Aug 2025, 17:28:08 UTC
Previous filing
04 Feb 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McManus Matthew President - Diag & Spatial Bio 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed. 19 Aug 2025 0001908268

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +2,637 +89% $0.000000 5,615 15 Aug 2025 Direct
transaction TECH Common Stock Tax liability $47,168 -880 -16% $53.60 4,735 15 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -2,637 -33% $0.000000 5,275 15 Aug 2025 Common Stock 2,637 Direct F1, F6
transaction TECH Performance Restricted Stock Units Award $0 +19,243 $0.000000 19,243 15 Aug 2025 Common Stock 19,243 Direct F1, F8
transaction TECH Restricted Stock Units Award $0 +9,622 $0.000000 9,622 15 Aug 2025 Common Stock 9,622 Direct F1, F9
transaction TECH Stock Option (Right to Buy) Award $0 +24,614 $0.000000 24,614 15 Aug 2025 Common Stock 24,614 $53.60 Direct F10
holding TECH Performance Restricted Stock Units 2,888 15 Aug 2025 Common Stock 2,888 Direct F1, F2
holding TECH Performance Stock Option (Right to Buy) 7,951 15 Aug 2025 Common Stock 7,951 $68.54 Direct F2
holding TECH Restricted Stock Units 9,241 15 Aug 2025 Common Stock 9,241 Direct F1, F3
holding TECH Stock Option (Right to Buy) 15,902 15 Aug 2025 Common Stock 15,902 $68.54 Direct F4
holding TECH Performance Restricted Stock Units 15,825 15 Aug 2025 Common Stock 15,825 Direct F1, F5
holding TECH Stock Option (Right to Buy) 21,320 15 Aug 2025 Common Stock 21,320 $74.91 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
F4 Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
F5 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.
F7 Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F8 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.
F10 Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.